Human Medicines

This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
Summary of CMDh activities 2022
modified 16/03/2023
List of active substances for which data has been submitted in accordance with…
modified 09/03/2023
Added in March 2023
1 March
NEW - Report from the meeting held on 21-22…
modified 01/03/2023
Hiberix (Haemophilus influenzae type b vaccine) End of procedure:…
added 01/03/2023
Certican (everolimus) SE/W/0025/pdWS/001 End of procedure:01/06/2017 Date…
modified 01/03/2023
Hydroxychloroquine Date of publication: 01/03/2023
modified 01/03/2023
Position paper on common grounds seen for invalidation/delaying day 0 for…
modified 01/03/2023
Renewals
modified 01/03/2023
CMDh Best Practice Guide on the processing of renewals in the MRP/DCP
modified 01/03/2023
CMDh letter to MAHs of tenofovir disoproxil-containing medicinal…
modified 01/03/2023